243 related articles for article (PubMed ID: 32013195)
21. ARD1/NAA10 in hepatocellular carcinoma: pathways and clinical implications.
Lee D; Jang MK; Seo JH; Ryu SH; Kim JA; Chung YH
Exp Mol Med; 2018 Jul; 50(7):1-12. PubMed ID: 30054466
[TBL] [Abstract][Full Text] [Related]
22. Interaction between HIF-1 alpha (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1 alpha.
Arnesen T; Kong X; Evjenth R; Gromyko D; Varhaug JE; Lin Z; Sang N; Caro J; Lillehaug JR
FEBS Lett; 2005 Nov; 579(28):6428-32. PubMed ID: 16288748
[TBL] [Abstract][Full Text] [Related]
23. The protein acetyltransferase ARD1: a novel cancer drug target?
Arnesen T; Thompson PR; Varhaug JE; Lillehaug JR
Curr Cancer Drug Targets; 2008 Nov; 8(7):545-53. PubMed ID: 18991565
[TBL] [Abstract][Full Text] [Related]
24. A novel NAA10 variant with impaired acetyltransferase activity causes developmental delay, intellectual disability, and hypertrophic cardiomyopathy.
Støve SI; Blenski M; Stray-Pedersen A; Wierenga KJ; Jhangiani SN; Akdemir ZC; Crawford D; McTiernan N; Myklebust LM; Purcarin G; McNall-Knapp R; Wadley A; Belmont JW; Kim JJ; Lupski JR; Arnesen T
Eur J Hum Genet; 2018 Sep; 26(9):1294-1305. PubMed ID: 29748569
[TBL] [Abstract][Full Text] [Related]
25. [Production of anti-recombinant human arrest defective 1 protein (hARD1) monoclonal antibodies for assaying human breast cancer tissues].
Yu M; Wang Z; Gong J; Ma M; Jiao Y; Huang W; Lü Q; Li L; Yang H; Tan D
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):57-62. PubMed ID: 20353093
[TBL] [Abstract][Full Text] [Related]
26. Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase.
Arnesen T; Betts MJ; Pendino F; Liberles DA; Anderson D; Caro J; Kong X; Varhaug JE; Lillehaug JR
BMC Biochem; 2006 Apr; 7():13. PubMed ID: 16638120
[TBL] [Abstract][Full Text] [Related]
27. A Saccharomyces cerevisiae model reveals in vivo functional impairment of the Ogden syndrome N-terminal acetyltransferase NAA10 Ser37Pro mutant.
Van Damme P; Støve SI; Glomnes N; Gevaert K; Arnesen T
Mol Cell Proteomics; 2014 Aug; 13(8):2031-41. PubMed ID: 24408909
[TBL] [Abstract][Full Text] [Related]
28. Structure and Mechanism of Acetylation by the N-Terminal Dual Enzyme NatA/Naa50 Complex.
Deng S; Magin RS; Wei X; Pan B; Petersson EJ; Marmorstein R
Structure; 2019 Jul; 27(7):1057-1070.e4. PubMed ID: 31155310
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the native and fibrillar conformation of the human Nalpha-acetyltransferase ARD1.
Sánchez-Puig N; Fersht AR
Protein Sci; 2006 Aug; 15(8):1968-76. PubMed ID: 16823041
[TBL] [Abstract][Full Text] [Related]
30. NAA10 as a New Prognostic Marker for Cancer Progression.
Kim SM; Ha E; Kim J; Cho C; Shin SJ; Seo JH
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126484
[TBL] [Abstract][Full Text] [Related]
31. Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation.
Lim JH; Park JW; Chun YS
Cancer Res; 2006 Nov; 66(22):10677-82. PubMed ID: 17108104
[TBL] [Abstract][Full Text] [Related]
32. Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans.
Arnesen T; Van Damme P; Polevoda B; Helsens K; Evjenth R; Colaert N; Varhaug JE; Vandekerckhove J; Lillehaug JR; Sherman F; Gevaert K
Proc Natl Acad Sci U S A; 2009 May; 106(20):8157-62. PubMed ID: 19420222
[TBL] [Abstract][Full Text] [Related]
33. The N-terminal acetyltransferase Naa10 is essential for zebrafish development.
Ree R; Myklebust LM; Thiel P; Foyn H; Fladmark KE; Arnesen T
Biosci Rep; 2015 Aug; 35(5):. PubMed ID: 26251455
[TBL] [Abstract][Full Text] [Related]
34. NAA10-related syndrome.
Wu Y; Lyon GJ
Exp Mol Med; 2018 Jul; 50(7):1-10. PubMed ID: 30054457
[TBL] [Abstract][Full Text] [Related]
35. Arrest defective 1 regulates the oxidative stress response in human cells and mice by acetylating methionine sulfoxide reductase A.
Shin SH; Yoon H; Chun YS; Shin HW; Lee MN; Oh GT; Park JW
Cell Death Dis; 2014 Oct; 5(10):e1490. PubMed ID: 25341044
[TBL] [Abstract][Full Text] [Related]
36. NAT6 acetylates the N-terminus of different forms of actin.
Wiame E; Tahay G; Tyteca D; Vertommen D; Stroobant V; Bommer GT; Van Schaftingen E
FEBS J; 2018 Sep; 285(17):3299-3316. PubMed ID: 30028079
[TBL] [Abstract][Full Text] [Related]
37. Investigating the functionality of a ribosome-binding mutant of NAA15 using Saccharomyces cerevisiae.
Varland S; Arnesen T
BMC Res Notes; 2018 Jun; 11(1):404. PubMed ID: 29929531
[TBL] [Abstract][Full Text] [Related]
38. Biochemical analysis of novel NAA10 variants suggests distinct pathogenic mechanisms involving impaired protein N-terminal acetylation.
McTiernan N; Tranebjærg L; Bjørheim AS; Hogue JS; Wilson WG; Schmidt B; Boerrigter MM; Nybo ML; Smeland MF; Tümer Z; Arnesen T
Hum Genet; 2022 Aug; 141(8):1355-1369. PubMed ID: 35039925
[TBL] [Abstract][Full Text] [Related]
39. NAA10 p.(N101K) disrupts N-terminal acetyltransferase complex NatA and is associated with developmental delay and hemihypertrophy.
McTiernan N; Gill H; Prada CE; Pachajoa H; Lores J; ; Arnesen T
Eur J Hum Genet; 2021 Feb; 29(2):280-288. PubMed ID: 32973342
[TBL] [Abstract][Full Text] [Related]
40. Human Naa50 Protein Displays Broad Substrate Specificity for Amino-terminal Acetylation: DETAILED STRUCTURAL AND BIOCHEMICAL ANALYSIS USING TETRAPEPTIDE LIBRARY.
Reddi R; Saddanapu V; Chinthapalli DK; Sankoju P; Sripadi P; Addlagatta A
J Biol Chem; 2016 Sep; 291(39):20530-8. PubMed ID: 27484799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
